Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
Kapila Viges
Kapila Viges
Kapila Viges is the Executive Director of the MPN Research Foundation.
Articles by Kapila Viges
Selinexor in MPNs: Optimizing What's Available
John Mascarenhas, MD
Myelofibrosis
|
February 18, 2025
Discussing the evolving role of selinexor in treatment of myeloproliferative neoplasms.
View More
The Importance of Patient-Centered Treatment in MPNs
John Mascarenhas, MD
Myelofibrosis
|
February 18, 2025
Watch as Viges and Dr. Mascarenhas explore strategies to enhance patient-centered care in MPN management.
View More
Ongoing Research Aims to Fill Gaps in Myelofibrosis Care
John Mascarenhas, MD
Myelofibrosis
|
February 18, 2025
Exploring the latest advancements in myelofibrosis research with Kapila Viges, MD and John Mascarenhas, MD.
View More
Advancing Treatment Evaluation With Surrogate End Points in MPNs
John Mascarenhas, MD
Myeloproliferative Neoplasms
|
February 18, 2025
Two experts discuss the role of surrogate end points in MPN clinical trials.
View More